
What We’re Reading: Drug Firms Retain Vaccine Prepayments; FDA Revamps Food Leadership; Drug Decriminalization in Canada
Pharmaceutical companies will not refund prepayments made by global organization Gavi for COVID-19 vaccines it no longer needs; following the countrywide baby formula shortage of 2022, the FDA looks to consolidate food division leadership; a province in Canada starts a 3-year drug decriminalization program to try to reduce drug overdose deaths.
Vaccine Manufacturers Hold On to $1.4 Billion for Prepaid COVID-19 Shots for Global Poor
Due to dwindling demand for COVID-19 vaccines, Gavi, the organization tasked with vaccinating the poor internationally, is desperately trying to escape the deals it made with pharmaceutical companies to purchase now unneeded vaccines,
FDA to Streamline Following Baby Formula Criticism
FDA Commissioner Robert Califf reacted to criticism of the FDA’s response to the baby formula shortages and other food safety worries by proposing to put one deputy commissioner in charge of food policy and regulation,
Canadian Province Decriminalizes Drugs in Attempt to Reduce Overdoses
On Tuesday, the western Canadian province of British Columbia started a 3-year pilot program to decriminalize the possession of small amounts of heroin, meth, ecstasy, or crack cocaine in an attempt to battle a drug overdose crisis,
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.